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ABSTRACT 
 
Background: Since 2009, all eligible persons in England have been entitled to an NHS Health Check.  
Uncertainty remains about who attends and the health-related impact. 
Aim: To review quantitative evidence on coverage (the proportion of eligible individuals who attend), 
uptake (proportion of invitees who attend) and impact of NHS Health Checks. 
Design: A systematic review and quantitative data synthesis. 
Data sources: Eleven databases and additional internet sources were searched to November 2016. 
Inclusion criteria: Studies or data reporting coverage or uptake and studies reporting any health-related 
impact which used an appropriate comparison group or before-and-after study design. 
Results: Twenty-six observational studies and one additional dataset were included. Since 2013, 45.6% 
of eligible individuals have received an NHS Health Check. Coverage is higher among older people, 
those with a family history of coronary heart disease, those living in the most deprived areas, and some 
ethnic-minority groups. Just under half (48.2%) of those invited have taken up the invitation. Data on 
uptake and impact (especially regarding health-related behaviours) are limited.  Uptake is higher in older 
people and women but lower in those living in the most deprived areas. Attendance is associated with 
small increases in disease detection, decreases in modelled CVD risk and increased statin and anti-
hypertensive prescribing. 
Conclusion: Published attendance, uptake and prescribing rates are all lower than originally anticipated 
and data on impact are limited, with very few studies reporting the effect of attendance on health-related 
behaviours. High-quality studies comparing matched attendees and non-attendees and health economic 
analyses are required.  
 
Word count: 250 
 
Key words: NHS Health Check, uptake, coverage, impact, systematic review 
 
How this fits in:  Simultaneous nationwide rollout in 2009 of the NHS Health Check programme was 
based on some strong assumptions about the likely impact of the programme.  Almost a decade on, there 
remains much uncertainty about who attends and the overall health benefits.  This article presents the 
first systematic review of quantitative data from the programme.  Although we found attendance is much 
ORZHU WKDQ RULJLQDOO\ DQWLFLSDWHG DWWHQGHHV FDQQRW EH UHDGLO\ FKDUDFWHULVHG DV WKH ³ZRUULHG ZHOO´ RU
³HDVLHVWWRUHDFK´   
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INTRODUCTION 
The NHS Health Check programme was launched in England in 2009 as part of a healthcare strategy 
aimed at ³HPSRZHULQJSDWLHQWVDQGSUHYHQWLQJLOOQHVV´.[1] It offers everyone aged 40-74 years without 
pre-existing cardiovascular disease (CVD), chronic kidney disease (CKD), type 2 diabetes (T2DM) or 
dementia an assessment of their risk of having or developing such conditions and advice about relevant 
medications and lifestyle changes every five years.  Since 2013, local authorities have had a statutory 
responsibility to offer the programme to all eligible individuals, with funding provided by Public Health 
England (PHE)[2].  Echoing similar efforts in other countries to provide preventive health checks[3, 4], 
the programme is delivered by various providers, predominantly general practices. 
 
The programme was introduced simultaneously nationwide without robust economic evaluation evidence 
from a randomised controlled trial (RCT) , and with very limited available evidence on health check 
strategies implemented in other countries[5, 6].  However, the Department of Health modelled the 
potential long-term cost-effectiveness of the programme[7]. In that modelling it was envisaged that all 
those eligible would be invited for an NHS Health Check during the first five year cycle.  Based on 
evidence from a national breast screening programme it was expected that 75% would attend.[7]  Of 
those attendees with high cholesterol or CVD risk (10-\HDU  it was hoped that 85% would be 
prescribed statins (in 50% of cases, this was attributed directly to the health check).  Using a time 
horizon of a lifetime, the cost-effectiveness of the programme was predicted in this modelling to be 
£2,866 per QALY (quality adjusted life year) (2015/16 prices[8]), well within the limit of what would 
normally be deemed cost-effective by NICE[9].   
 
The objectives of this study were to systematically identify and synthesize available evidence on: (1) 
coverage (the proportion of the eligible population who have attended an NHS Health Check) and 
variation in coverage; (2) uptake (the proportion of those invited who have attended an NHS Health 
Check) and variation in uptake; and (3) the effect of the programme, in order to provide up-to-date 
estimates of its delivery and impact. 
 
METHODS 
Search strategy and study selection 
Full details of the search strategy are given in Appendix 1 and the study selection process is described in 
detail elsewhere[10].  Briefly, searches included eleven literature databases and additional internet 
sources encompassing both peer-reviewed and grey literature relevant to NHS Health Checks published 
up to November 2016. 
 
Inclusion criteria 
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Quantitative observational data or analyses (cross-sectional or longitudinal) which included people 
eligible for an NHS Health Check and reported evidence on coverage or uptake were included. Impact 
studies reporting any health-related outcome which used an appropriate comparison group or a before-
and-after study design were also included. Data or analyses relating to other screening or health check 
services which were not NHS Health Checks were excluded, as were editorials and opinion pieces. 
 
Data extraction, quality assessment and synthesis 
Data were extracted independently by three researchers (JUS, AM and CS) using forms devised for this 
study.  Reflecting the wide range of study designs, data and methods identified, existing CASP 
checklists[11] were adapted for the quality assessment of identified studies. 
 
For each objective, we grouped studies according to their design.  Since the programme runs in 5 year 
cycles, where necessary we adjusted reported coverage to a standardised measure of coverage per year 
per one fifth of the total eligible population (which can lead to coverage exceeding 100% if more than 
20% of the eligible population attend in a given year). We categorised the health-related impact studies 
(objective 3) into four groups (disease detection, health-related behaviours, prescribing and individual-
risk factors) and report the results in order of the degree to which observed differences between groups 
can be attributed to NHS Health Check attendance.   
 
RESULTS 
 
Overview of included studies 
The searches identified 18,524 articles.  We reviewed 178 full-text articles and 26 (including five from 
the grey literature[12±16]) were deemed relevant (Figure 1).  All were observational studies. Seven used 
data from large, routine, consolidated datasets with nationwide reach (including the Clinical Practice 
Research Datalink (CPRD)[17±20], QResearch[21] and prescribing data[15]); 19 used local data from 
general practices (n=17) or community settings (n=2) collected in particular geographic areas [12, 16].  
Eleven studies were assessed as high quality (Appendix Table A1).  In addition to the 26 included 
observational studies, data identified in the additional internet searches were also extracted from PHE¶V
website.[22] 
  
Objective 1:  Coverage (n=10) 
The PHE website included data on national-level coverage during the first 3.5 years of the current five 
year cycle (2013-4, when the NHS Health Check became a statutory requirement, to second quarter (Q2), 
2016-7) as well as variation in coverage over time (per quarter) and by area (at the county level).  Nine 
further studies reported data on coverage[13, 18, 21, 23±28] (Table 1).   
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1a. Reported coverage 
The PHE website reported coverage of 45.6% for the whole of England (2013-4 to Q2, 2016-7), ranging 
from 18.9% in Surrey to 109.2% in Newham[22].  Where full-year data were available, national 
coverage varied between 48.1% in 2014-15 to 45.0% in 2015-6.  Three of the nine published studies used 
national-level data from earlier years. [18, 21, 24] The reported coverage ranged from 8.1% (2011-
2012)[24] to 26.7% (2009-2013)[18].  The other six studies reported data from samples of general 
practices, with coverage ranging from 20% (2010-11 in Hammersmith and Fulham) [23] to 73% (2011-
12 in north-east London) [29] (Table 1).   
 
1b Variation in coverage  
Three studies used multiple regression to identify factors associated with differences in coverage 
between population groups.[18, 23, 24]  The findings from these are summarised in Table 2. Two used 
patient-level data. Both showed higher coverage among older people and those with a family history of 
coronary heart disease. The study by Artac et al. additionally reported higher coverage amongst non-
smokers, those in the most deprived tertile, those without CVD co-morbidities, those registered with 
larger general practices, and among people from Black and South Asian ethnic groups.[23] By contrast, 
the study by Chang et al. found no significant association between coverage and deprivation and a lower 
coverage among people from Black African and Other Black ethnic groups.[18] The third study used 
data from 151 primary care trusts (PCT) and found those in the most deprived tertile were significantly 
more likely to have attended a health check, but no significant associations for age, ethnicity, population 
size and other PCT-level measures.[24] 
 
A further five studies reported coverage for different population sub-groups without adjustment for 
covariates (Appendix Table A2) [18, 21, 23, 26, 27]  The two that used data from large datasets with 
nationwide reach GXULQJ WKH SURJUDPPH¶V ILUVW IRXU \HDUV VKRZHG KLJKHU FRYHUDJH DPRQJVW IHPDOHV
older people and those living in more deprived areas.[18, 21] 
 
Objective 2:  Uptake (n=11) 
The PHE website included data on national-level uptake (2013-4 to Q2, 2016-7) as well as variation in 
uptake over time (per quarter) and by area (at the county level).  Eleven studies reported uptake and 
socioeconomic factors associated with uptake in general practices (n=9) [12, 14, 16, 26, 27, 30±35] and 
community-based settings (n=2).[12, 16]) The study samples were different from those used in the 
coverage studies and generally smaller, ranging from two[30] to 40[31] general practices incorporating 
between 1,380[34] and 50,485[26] patients.   
 
2a: Reported uptake 
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Table 3 shows the reported uptake across the data sources. The PHE website reported uptake of 48.2% 
for the whole of England (2013-4 to Q2, 2016-7), ranging from 20.1% in East Riding of Yorkshire to 
100% in Leicester.  Where full-year data were available, national uptake varied between 47.9% in 2015-
6 to 49.0% in 2013-14.  Uptake in the general practice studies (n=9) ranged from 27% (four practices in 
eastern England)[34] to 52.9% (13 practices in north-western England) [27].  Uptake in the community 
settings was 45.9% (a football ground) [16] and 71.8% (a mental healthcare unit).[12]  
 
2b:  Variation in uptake 
Five studies reported associations between patient characteristics and the likelihood of attending, using 
multivariable regression (Table 3). These consistently showed that the odds of taking up an invitation 
increased significantly with age and lower deprivation. Of the five studies reporting associations between 
uptake and sex, four also showed women were more likely to take up invitations. The fifth, a study of 37 
practices in Stoke-on-Trent[32], reported the opposite with men more likely to take-up invitations. Only 
two studies reported the effects of ethnicity. One was in 29 practices in Ealing (West London) and found 
invitees of South Asian or mixed ethnicity were more likely to attend than white British, whilst there was 
no difference for Black or Other groups and those with missing data were less likely to attend. [32] The 
other was across four general practices in the East of England and found no difference in uptake between 
participants of white and non-white ethnicity. [34]  
 
Five studies also reported unadjusted comparisons between invited attendees and non-attendees 
(Appendix Table A3).[26, 27, 32±34] All reported higher uptake in older people, but findings for 
deprivation were more mixed with two reporting higher uptake in those in the least deprived areas[26, 
33], one with higher uptake in the most deprived[34], and two with no significant differences[27, 32]. 
Notably, the association between deprivation and uptake in the unadjusted analysis of the study across 
four general practices in the East of England was in the opposite direction to the multivariable analysis 
which adjusted for GP practice (greater deprivation was associated with a higher odds of attending in 
unadjusted analysis in the study). As the authors of that study note, the GP practices had different 
distributions of deprivation and used different invitation methods, highlighting the importance of GP 
surgery characteristics when assessing uptake. Two studies also reported higher uptake in women and, 
where reported, uptake was higher in non-smokers, those with higher CVD risk and those with 
hypertension or raised cholesterol.   
 
Objective 3:  Impact (n=12) 
Twelve studies reported evidence on short-term impact.  Five included a comparison group (Table 4). Of 
these, two used CPRD data to examine individual-level differences over time between matched  
attendees and non-attendees[19, 20].  The other three reported population-level associations between 
coverage and outcome[15, 36, 37].  The remaining seven studies were before-and-after studies without 
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comparison groups (Appendix Table A4). No studies of long-term health impacts or economic 
evaluations were identified. 
 
3a:  Disease detection (n=4) 
The CPRD study by Chang et al. showed more frequent diagnosis of familial hypercholesterolemia, 
hypertension, CKD, peripheral vascular disease and T2DM amongst attendees compared to non-
attendees during the two years following attendance, whilst stroke diagnosis was significantly less likely. 
[20]  No significant differences in diagnoses of atrial fibrillation, coronary artery disease, heart failure or 
transient ischemic attack were observed. [20]  The CPRD study by Forster et al. also showed more 
frequent diagnosis of hypercholesterolemia (high cholesterol), and of hypertension amongst men (but not 
women)[19].  
 
Two further studies used small samples of general practices and reported associations between NHS 
Health Check coverage and disease detection after controlling for area-level characteristics (e.g. age 
profile and deprivation).[36, 37] The study by Caley et al.[36] identified no statistically significant 
associations between coverage and change in the prevalence of T2DM, hypertension, coronary heart 
disease, CKD or atrial fibrillation. However, the study only included 79 general practices and only 
13.6% of the eligible population had received an NHS Health Check so it was under-powered to detect 
small differences.  The second study by Lambert et al.[37] reported that the number of NHS Health 
Checks performed explained between 6% and 60% of the variance in incident hypertension across the 
different practices.   
 
3b:  Health-related behaviour (n=4) 
The only study with a comparison group to report health-related behaviour reported no significant 
association between change in smoking prevalence (recorded within primary care records over a median 
of two years) and attendance at a health check.[20]  Three studies reported change in smoking amongst 
individuals after attendance at a health check (Appendix Table A4).  Two[17, 38] showed a significant 
reduction of at least ten percentage points in the proportion of attendees who smoked, whereas in the 
other the change was not statistically significant[39].  Without a comparison group, however, it is not 
possible to attribute these changes to the NHS Health Check.  No other health-related behaviours were 
reported. 
 
3c:  Prescribing (n=9) 
The two CPRD studies  [19, 20] identified significantly greater increases in statin and anti-hypertensive 
prescriptions amongst attendees than matched non-attendees.  For example, new statin prescriptions were 
initiated for 5.6% of attendees, versus 1.2% of non-attendees over a median of two-years in one of the 
studies[20], and by 11.0% and 7.6% over four years in the other.[19]  Another study investigated 
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national-level prescribing data and showed a significant association between coverage and high-dose 
statin prescribing at the PCT level in 2011, however the association was not significant for low-dose 
statins.[15] 
 
Six before-and-after studies all showed an increased likelihood of a statin prescription following 
attendance (Appendix Table A4).[17, 18, 21, 27, 32, 39] The proportion prescribed statins after the 
health check ranged from 18.3% in one of the CPRD studies[17] to 49.9% in Hammersmith and 
Fulham[39]. 
 
3d: Individual risk factors and CVD risk (n=5) 
The CPRD study by Chang et al.[20]showed significant differences in BMI, blood pressure (BP) 
(systolic and diastolic), modelled CVD risk and total cholesterol between attendees and matched non-
attendees during a two-year period.[20] For example, the QRISK2 mean score (% 10-year risk) fell by 
0.21 (95% CI: 0.19 to 0.24), from 5.1 to 4.9 amongst non-attendees, compared to 6.7 to 6.2 amongst 
attendees, which is equivalent to the prevention of one cardiovascular event per 4,762 attendees.  
However, the sample used in the analysis was limited by missing data: only 2.3% of non-attendees had a 
follow-up QRISK2 score recorded. The population-level cross-sectional study by Lambert et al. also 
reported a strong negative association between the number of health checks provided in a particular area 
and incident cases of CVD.[37] 
 
Three further before-and-after studies of attendees[17, 38, 39] identified significant reductions in 
diastolic BP and cholesterol levels after 12-15 months (Appendix Table A4). Two of these also reported 
significant reductions in obesity, CVD risk and systolic BP. [17, 39]  However, the samples used in the 
analyses were also limited by missing data (e.g. follow-up data was unavailable for 50% of attendees in 
one study).[39]  
 
DISCUSSION 
 
Summary of main findings 
In the current five year cycle starting in 2013, the most recent available evidence shows that 45.6% of 
eligible adults across England have attended an NHS Health Check. This percentage varies substantially 
across the country, from 18.9% in some areas to over 100% in others.  Data from the identified studies 
shows higher coverage among older people, those with a family history of coronary heart disease, those 
living in the most deprived areas, and some ethnic groups. Uptake also varies substantially with just 
under half (48.2%) of all those invited taking up the invitation. In the selected samples of patients and 
general practices in the identified studies, the proportion accepting the invitation is also higher in older 
people and women but, in contrast with coverage, is lower in those living in the most deprived areas. The 
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impact studies comparing attendees with matched non-attendees showed that attendance is associated 
with small increases in disease detection above routine practice, an increased likelihood of statin and 
anti-hypertensive prescribing (with the percentage of those with a modelled 10-\HDU &9' ULVN 
prescribed statins following a health check ranging between 18% to 63%), and small decreases in 
modelled CVD risk (the best current evidence suggests that one cardiovascular event is prevented per 
4,762 attendees, equating to over 1,400 events across the country during a five year cycle).  Very few 
studies have reported the impact of attendance on health-related behaviours.   
 
Strengths and limitations 
Almost a decade since the programme was introduced, and five since it became a statutory responsibility 
of local authorities, this is the first synthesis of quantitative evidence related to delivery or impact. A 
strength of our study is the systematic searches, including the OpenGrey database and additional 
internet-based searches.  However, in the absence of randomised trials or a step wedge evaluation of a 
gradual roll-out of NHS Health Checks, the synthesis is limited by the quality of the included studies.  
Studies used different populations, time points (including before the programme become statutory in 
2013), databases, methods for identifying attendance , and (where multivariable regression was used) 
adjusted for different observable patient and general practice characteristics. Even for studies using 
electronic health records, coding was not reliable and so led to some researchers using combinations of 
entries to classify attendance[20]. This precluded the pooling of data from different studies. Whilst some 
studies (including the multivariable analyses of uptake (Table 3)) relied on relatively small samples of 
general practices and patients, even the larger consolidated databases did not include nationally 
representative samples of patients or general practices.  For example, general practices in the North of 
England are poorly represented in CPRD, and those which contribute data are larger[40] and potentially 
more engaged with research and preventive medicine than those who do not. Almost all studies relied on 
routinely collected data for patient characteristics and health outcomes.  Missing outcome data is 
therefore a particular problem as data are likely to be less complete in those people who have not 
attended a health check.   This may be the reason why those who have attended are more likely to have a 
family history of coronary heart disease recorded, for example.  There may also be systematic 
GLIIHUHQFHVLQWKRVHZKRDWWHQGKHDOWKFKHFNVDQGWKRVHZKRGRQ¶WOHDGLQJWRELDVLQWKHHVWLPDWHVRIWKH
impact of the programme based on studies with control groups. For example, those who have not 
attended a health check but do have a disease or risk factor recorded may be those in whom healthcare 
professionals have already clinically suspected disease, or those who consult more often.   
 
Implications for clinical practice, policy and research 
This study identified data showing that the anticipated coverage and uptake used in the Department of 
Health model were both too optimistic. When judged against the (ambitious) objective of inviting all 
eligible individuals in each five year cycle, and the expected aggregate gains in population health arising 
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from high coverage (expected in the model to be 75%), the evidence shows the programme has fallen 
considerably short of expectations.  Since this remains the objective[2], a question needs to be addressed 
about where the necessary resources and capacity should come from to achieve it.  Conversely, when 
judged against any reasonable value for money criteria, the identified evidence on attendance is 
insufficient to indicate a lack of cost-effectiveness.  In the economic models, lower than anticipated 
coverage, for example, would merely reduce aggregated costs and aggregated health gains, without 
affecting the cost per QALY estimates[7, 41].  Like other interventions (bariatric surgery for instance) 
and some pharmaceuticals (which might be subjected WR D ³EXGJHW LPSDFW WHVW´[42]),  it seems NHS 
health checks may thus be simultaneously cost-effective and unaffordable[41]. A pragmatic response 
might be to focus attention on targeting the distribution of NHS Health Checks towards those who would 
benefit most and/or towards reducing health inequalities. The finding that coverage (the proportion of the 
eligible population who have attended an NHS Health Check) amongst those in the most deprived areas 
was higher than average despite uptake (the proportion of those invited who have attended an NHS 
Health Check) amongst those groups being lower and the findings from the study by Attwood et al. in 
which the direction of association between socio-demographic characteristics and uptake was reversed 
after adjusting for GP practice[34] suggest that this is already happening to some degree.  Together with 
the finding that coverage was higher among older people, who will be at higher risk of CVD than 
younger people, this may go some way towards alleviating concerns amongst health professionals that 
attendees are predominantly WKHµZRUULHGZHOO¶or those least likely to benefit[43]. However, given that 
much of the data on coverage and uptake were from different sources, we suggest that this should be the 
focus of future research.  This could be supported, to some degree, through development of a slightly 
broader PHE dataset for the routine collection of a small number of variables on those invited and those 
who subsequently attend. In future years it will also be important to distinguish between those attending 
for the first time and those attending follow-up NHS Health Checks after five years.  
 
Whilst this study also showed statin prescribing to be below expectations, potentially increasing the cost 
per QALY, there remains a significant shortage of data on the health impacts, particularly longer term, 
and costs of health checks.  Alongside the data on attendance identified in this study, such data is 
necessary for revising key assumptions in economic models of health checks,[44, 45] not only in 
England, but potentially also internationally where similar data is also currently limited[46, 5]. There is 
also a need for further high-quality studies comparing matched attendees and non-attendees, including 
follow-up studies to quantify the impact of health check attendance on physical activity, diet, alcohol 
consumption, smoking, and potential harms such as false reassurance and anxiety which are currently 
unknown.  
 
 
Funding 
11 
 
This work was funded by a grant from Public Health England. JUS was funded by an NIHR Clinical 
Lectureship and FW by an NIHR Clinician Scientist award. JUS is now funded by a Cancer Research 
UK Prevention Fellowship (C55650/A21464). The views expressed in this publication are those of the 
authors and not necessarily those of the NHS, the NIHR or the Department of Health. 
 
All researchers were independent of the funding body and the funder had no role in data collection, 
analysis and interpretation of data; in the writing of the report; or decision to submit the article for 
publication.  
 
Acknowledgements 
We thank our patient and public representatives Kathryn Lawrence and Chris Robertson for providing 
helpful comments on the findings and the NHS Health Checks Expert Scientific and Clinical Advisory 
Panel working group for providing us with the initial literature search conducted by Public Health 
England.  
 
Contributors 
AM screened articles for inclusion, extracted and synthesised the data, interpreted the findings and wrote 
the first draft of the manuscript. CS extracted the data, interpreted the findings and critically revised the 
manuscript. EH screened articles for inclusion, interpreted the findings and critically revised the 
manuscript.  CMa interpreted the findings and critically revised the manuscript. SG, JM, CM and FW 
developed the protocol, interpreted the findings and critically revised the manuscript. JUS developed the 
protocol, screened articles for inclusion, extracted and synthesised the data, interpreted the findings and 
wrote the first draft of the manuscript. 
 
Competing Interests 
None declared. 
 
FIGURE LEGENDS 
Figure 1: PRISMA diagram 
Figure 2: Change in the percentage of people being prescribed statins before and after attending an NHS 
Health Check 
 
REFERENCES 
1. Announcement of health checks 
[http://webarchive.nationalarchives.gov.uk/+/www.dh.gov.uk/en/Healthcare/Longtermcondition
s/Vascular/NHShealthcheck/index.htm] 
12 
 
2. NHS Health Checks: applying All Our Health 
[https://www.gov.uk/government/publications/nhs-health-checks-applying-all-our-health/nhs-
health-checks-applying-all-our-health] 
3HUN-'H%DFNHU**RKONH+*UDKDP,5HLQHUä9HUVFKXUHQ:00$OEXV&%HQOLDQ3
Boysen G, Cifkova R, Deaton C, Ebrahim S, Fisher M, Germano G, Hobbs R, Hoes A, 
Karadeniz S, Mezzani A, Prescott E, Ryden L, Scherer M, Syvänne M, Scholte Op Reimer 
WJM, Vrints C, Wood D, Zamorano JL, Zannad F: European Guidelines on cardiovascular 
disease prevention in clinical practice (version 2012): The Fifth Joint Task Force of the 
European Society of Cardiology and Other Societies on Cardiovascular Disease 
Prevention in Clinical Practice (constituted by representatives of nine societies and by 
invited experts). Atherosclerosis 2012, 223:1±68. 
4. Package of Essential Noncommunicable (PEN) Disease Interventions for Primary 
Health Care in Low-Resource Settings 
[http://apps.who.int/iris/bitstream/10665/44260/1/9789241598996_eng.pdf] 
5. Schuetz CA, Alperin P, Guda S, van Herick A, Cariou B, Eddy D, Gumprecht J, Nicolucci A, 
Schwarz P, Wareham NJ, Witte DR, Smith U: A Standardized Vascular Disease Health 
Check in Europe: A Cost-Effectiveness Analysis. PLoS One 2013, 8:e66454. 
6. Lee JT, Lawson KD, Wan Y, Majeed A, Morris S, Soljak M, Millett C: Are cardiovascular 
disease risk assessment and management programmes cost effective? A systematic review 
of the evidence. Prev Med (Baltim) 2017, 99:49±57. 
7. Department of Health. Economic Modelling for Vascular Checks 
[www.healthcheck.nhs.uk/document.php?o=225] 
8. Unit Costs of Health and Social Care 2016 [http://www.pssru.ac.uk/project-pages/unit-
costs/unit-costs-2016/] 
9. Claxton K, Martin S, Soares M, Rice N, Spackman E, Hinde S, Devlin N, Smith PC, Sculpher 
M: Methods for the estimation of the National Institute for Health and Care Excellence 
cost-effectiveness threshold. Health Technol Assess (Rockv) 2015, 19:1±504. 
10. Usher-Smith J, Harte E, MacLure C, Martin A, Saunders C, Meads C, Walter F, Griffin S, 
Mant J: Patient experience of NHS Health Checks: a systematic review and qualitative 
synthesis. BMJ Open 2017. 
11. Critical Appraisal Skills Programme (CASP) Checklists [http://www.casp-uk.net/casp-
tools-checklists] 
12. Coffee S: Engaging Mental Health Service Users in Solihull with the NHS Health 
Check programme: a community pilot project. 2015. 
13 
 
13. Coffey M, Cooper AM, Brown TM, Cook PA, Clarke-Cornwell AM: Vascular Health 
Checks in Salford: An exploration using FARSITE data. 2014. 
14. Coghill N: Improving the uptake of NHS Health Checks in more deprived communities 
XVLQJ ³ RXWUHDFK ´ WHOHSKRQH FDOOV PDGH E\ VSHFLDOLVW KHDOWK DGvocates from the same 
FRPPXQLWLHVௗ$TXDQWLWDWLYHVHUYLFHHYDOXDWLRQ. 2016. 
15. Jamet G, Tubeuf S, Meads D: Leeds Institute of Health Sciences Has the introduction of 
1+6KHDOWKFKHFNVLQFUHDVHGWKHSUHVFULSWLRQRIVWDWLQVIRU&9'SUHYHQWLRQௗ" 2014. 
16. NHS Greenwich: Evaluation of NHS Health Check PLUS Community Outreach 
Programme in Greenwich. 2011:1±61. 
17. Forster AS, Dodhia H, Booth H, Dregan A, Fuller F, Miller J, Burgess C, McDermott L, 
Gulliford MC: Estimating the yield of NHS Health Checks in England: A population-based 
cohort study. J Public Heal (United Kingdom) 2015, 37:234±240. 
18. Chang K-M, Soljak M, Lee JT, Woringer M, Johnston D, Khunti K, Majeed A, Millett C: 
Coverage of a national cardiovascular risk assessment and management programme (NHS 
Health Check): Retrospective database study. Prev Med (Baltim) 2015, 78:1±8. 
19. Forster AS, Burgess C, Dodhia H, Fuller F, Miller J, McDermott L, Gulliford MC: Do 
health checks improve risk factor detection in primary care? Matched cohort study using 
electronic health records. J Public Health (Bangkok) 2015:1±8. 
20. Chang K, Lee J, Vamos E, Solijak M, Johnston D, Khunti K, Majeed A, Millett C: Impact 
of the National Health Service Health Check on cardiovascular disease risk: a difference-
in-differences matching analysis. CMAJ 2016, 188:E228-238. 
21. Robson J, Dostal I, Sheikh A, Eldridge S, Madurasinghe V, Griffiths C, Coupland C, 
Hippisley-Cox J: The NHS Health Check in England: an evaluation of the first 4 years. 
BMJ Open 2016, 6:e008840. 
22. Public Health England data on NHS Health Checks 
[http://fingertips.phe.org.uk/profile/nhs-health-check-detailed/data#page/0] 
23. Artac M, Dalton ARH, Majeed A, Car J, Huckvale K, Millett C: Uptake of the NHS Health 
Check programme in an urban setting. Fam Pract 2013, 30:426±35. 
24. Artac M, Dalton ARH, Babu H, Bates S, Millett C, Majeed A: Primary care and 
population factors associated with NHS Health Check coverage: A national cross-sectional 
study. J Public Heal (United Kingdom) 2013, 35:431±439. 
25. Baker C, Loughren EA, Crone D, Kallfa N: A process evaluation of the NHS Health 
Check care pathway in a primary care setting. J Public Health (Oxf) 2015, 37:202±209. 
26. Cook EJ, Sharp C, Randhawa G, Guppy A, Gangotra R, Cox J: Who uses NHS health 
14 
 
checks? Investigating the impact of ethnicity and gender and method of invitation on 
uptake of NHS health checks. Int J Equity Health 2016, 15:13. 
27. Krska J, du Plessis R, Chellaswamy H: Implementation of NHS Health Checks in general 
practice: variation in delivery between practices and practitioners. Prim Health Care Res 
Dev 2015(April 2009):1±8. 
28. Robson J, Dostal I, Madurasinghe V, Sheikh  a., Hull S, Boomla K, Page H, Griffiths C, 
Eldridge S: The NHS Health Check programme: implementation in east London 2009-
2011. BMJ Open 2015, 5:e007578±e007578. 
29. Robson J, Dostal I, Madurasinghe V, Sheikh A, Hull S, Boomla K, Page H, Griffiths C, 
Eldridge S: The NHS Health Check programme: implementation in east London 2009-
2011. BMJ Open 2015, 5:e007578. 
30. Kumar J, Chambers R, Mawby Y, Leese C, Lqbal Z, Picariello L, Richardson D: Delivering 
more with less? Making the NHS Health Check work in financially hard times: Real time 
learning from Stoke-on-Trent. Qual Prim Care 2011, 19:193±199. 
31. Hooper J, Chohan P, Caley M: Case detection of disease by NHS Health Checks in 
Warwickshire, England and comparison with predicted performance. Public Health 2014, 
128:475±477. 
32. Dalton ARH, Bottle A, Okoro C, Majeed A, Millett C: Uptake of the NHS Health Checks 
programme in a deprived, culturally diverse setting: cross-sectional study. J public Heal 
(Oxford, Engla 2011, 33:422±9. 
33. Cochrane T, Gidlow CJ, Kumar J, Mawby Y, Iqbal Z, Chambers RM: Cross-sectional 
review of the response and treatment uptake from the NHS Health Checks programme in 
Stoke on Trent. J Public Heal (United Kingdom) 2013, 35:92±98. 
34. Attwood S, Morton K, Sutton S: Exploring equity in uptake of the NHS Health Check 
and a nested physical activity intervention trial. J Public Health (Bangkok) 2015, 38:fdv070. 
35. Sallis A, Bunten A, Bonus A, James A, Chadborn T, Berry D: The effectiveness of an 
enhanced invitation letter on uptake of National Health Service Health Checks in primary 
care: a pragmatic quasi-randomised controlled trial. BMC Fam Pract 2016, 17:35. 
36. Caley M, Chohan P, Hooper J, Wright N: The impact of NHS health checks on the 
prevalence of disease in general practices: A controlled study. Br J Gen Pract 2014, 64:516±
521. 
37. Lambert MF: Assessing potential local routine monitoring indicators of reach for the 
NHS health checks programme. Public Health 2016, 131:92±98. 
38. Cochrane T, Davey R, Iqbal Z, Gidlow C, Kumar J, Chambers R, Mawby Y: NHS health 
15 
 
checks through general practice: randomised trial of population cardiovascular risk 
reduction. BMC Public Health 2012, 12:944. 
39. Artac M, Dalton ARH, Majeed A, Car J, Millett C: Effectiveness of a national 
cardiovascular disease risk assessment program (NHS Health Check): results after one 
year. Prev Med (Baltim) 2013, 57:129±34. 
40. Campbell J, Dedman D, Eaton S, Gallagher A, Williams T: Is the CPRD GOLD 
Population Comparable to the U.K. Population? Pharmacoepidemiol Drug Saf 2013, 22:280. 
41. Hinde S, Bojke L, Richardson G, Retat L, Webber L: The cost-effectiveness of population 
Health Checks: have the NHS Health Checks been unfairly maligned? J Public Health 
(Bangkok) 2017, 25:425±431. 
42. National Institute for Health and Care Excellence.: Budget Impact Test. 2017. 
43. Mills K, Harte E, Martin A, MacLure C, Griffin SJ, Mant J, Meads C, Saunders CL, Walter 
FM, Usher-Smith JA: Views of commissioners, managers and healthcare professionals on 
the NHS Health Check programme: a systematic review. BMJ Open 2017, 7:e018606. 
44. Crossan C, Lord J, Ryan R, Nherera L, Marshall T: Cost effectiveness of case-finding 
strategies for primary prevention of cardiovascular disease: a modelling study. Br J Gen 
Pract 2016(August):1±11. 
45. Kypridemos C, Allen K, Hickey GL, Guzman-Castillo M, Bandosz P, Buchan I, Capewell 
6 2¶)ODKHUW\ 0 Cardiovascular screening to reduce the burden from cardiovascular 
disease: microsimulation study to quantify policy options. BMJ 2016, 353:i2793. 
46. Lee JT, Lawson KD, Wan Y, Majeed A, Morris S, Soljak M, Millett C: Are cardiovascular 
disease risk assessment and management programmes cost effective? A systematic review 
of the evidence. Prev Med (Baltim) 2017, 99:49±57. 
 
  
16 
 
Table 1: Overall Coverage  
 
Author 
/ Year 
 
Setting  
and time period 
Coverage per one fifth 
of the total eligible 
population 
NATIONAL LEVEL  
Public Health 
England[22] 
England 
2013-4 to Q2 2016-7 
45.6% 
Artac 2013[24] 
 
England 
2011-12 
8.1% 
Chang 2015[18] 
 
England 
2009-13 
26.7% 
Robson 2016[21]  England 
2009-12 
12.8% 
REGIONAL LEVEL  
Artac 2013[23] 
 
 
27 (of 31) PCTs in 
Hammersmith and Fulham 
2008-09 
2010-11 
2008-09:32.7% 
2010-11:20.0% 
 
Baker  
2015[25] 
 
83 (of 85) practices in 
Gloucestershire 
2011-12 
49.8% 
Coffey 2014[13] 
 
40 (of 47) practices in Salford 
2013-14 
34% 
Cook 2016[26] 
 
Not reported 
2013-14 
56.5% 
Krska 
2015[27] 
 
13 (of 55) GP practices in 
Sefton, North West England 
2011-12 
47.2% 
Robson 2015[29] 
 
 
3 PCTs in East London 
2009-10 
2010-11 
2011-12 
2009-10: 33.9%  
2010-11: 60.6% 
2011-12: 73.4% 
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Table 2:  Associations between coverage and area-level or individual-level characteristics from multivariable adjusted studies 
Author 
/ Year 
 
Description of 
analysis  
Age Gender Ethnicity Deprivation  Smoker Family history of 
CHD 
 
Other 
Artac 
2013[24] 
 
Multivariable 
linear 
regression 
comparing 
PCT-level 
characteristics  
Highest proportion of 
PCT population in 
40-74 age range 
compared to lowest 
Coefficient -0.03  
(-0.87-0.36) p=0.668 
Not reported Highest proportion of 
PCT population of 
minority ethnicity 
compared to lowest 
Coefficient 0.08  
(-0.17-0.95) p=0.424 
Least deprived 
tertile compared 
to most deprived: 
Coefficient -0.51  
(-1.88-0.0) 
p=0.035* 
 
--- --- Population size, QOF 
points, patient 
experience, FTE GPs, 
estimated proportion 
at high-risk and 
estimated CVD 
prevalence: ns 
Chang 
2015[18] 
 
 
Multilevel 
logistic 
regression of 
individual-
level patient 
characteristics  
Compared to 40-49 
years: 
Aged 50-59: 
1.60 (1.54-1.67)* 
Aged 60-69: 
2.47 (2.36-2.58)* 
Aged 70-74: 
2.88 (2.49-3.31)* 
Female: 
1.01 (0.98-1.05) 
 
  
Compared to White: 
Black African:  
0.75 (0.61-0.92)* 
Chinese:  
0.68 (0.47-0.96)* 
Other White:  
0.35 (0.33-0.37)* 
Other Black:  
0.58 (0.46-0.74)* 
Not recorded:  
0.18 (0.17-0.19)* 
Prefer not to state:  
0.47 (0.41-0.53)*  
Irish: ns 
Indian: ns 
Pakistani/Bangladeshi: ns 
Other Asian: ns 
Caribbean: ns 
Most deprived 
quintile compared 
to least deprived: 
0.91 (0.63-1.31) 
--- Positive family 
history compared 
to no family 
history: 
2.37 (2.22-2.53)* 
 
--- 
Artac 
2013[23] 
 
Multilevel 
logistic 
regression of 
individual-
level patient 
characteristics 
using data on 
27 (of 31) 
PCTs in 
London 
Compared to 40-54 
years: 
Aged 55-64 
Y1: 1.34 (1.11-1.61)* 
Y2: 1.79 (1.67-1.93)* 
Aged 65-74 
Y1: 2.05 (1.67-2.52)*  
Y2: 2.79 (2.49-3.12)* 
Female: 
Y1: 
0.80 (0.67-0.94)* 
Y2: 
1.27 (1.20-1.35)* 
 
Compared to White: 
Black  
Y1:1.05 (0.78-1.41) 
Y2: 1.58 (1.43-1.75)* 
South Asian  
Y1:1.27 (0.88-1.87) * 
Y2: 1.50 (1.25-1.78)* 
Not recorded: 
Y1: 0.11 (0.07-0.17)* 
Y2: 0.08 *0.07-0.10)* 
Least deprived 
tertile compared 
to most deprived: 
Y1: 
0.84 (0.69-1.01) 
Y2: 
0.80 (0.73-0.87)* 
Current smokers 
compared to 
non-smokers: 
Y1: 
0.71 (0.61-0.83)* 
Y2: 
0.83 (0.77-0.90)* 
Positive family 
history compared 
to no family 
history: 
Y1: 
2.49 (2.15-2.90)* 
Y2: 
2.01 (1.87-2.16)* 
 
Presence of non-
CVD co-morbidities: 
Y1: 1.53 (1.13-1.80)* 
Y2: 1.75 (1.64-1.87)* 
Practice list size: 
>10,000 compared to 
<6000 
Y1: 1.16 (0.51-2.65) 
Y2: 6.05 (0.85-43.4)* 
 * p<0.05   ns: not significant. Results presented as adjusted odds ratios unless stated otherwise. PCT ± Primary Care Trust; QOF ± Quality Outcomes Framework; FTE ± full time 
equivalent; CVD ± cardiovascular disease;   
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Table 3: Uptake and variation in uptake of NHS Health Checks 
Study characteristics Uptake Multi-variable logistic regression analysis of individual-level factor affecting uptake of NHS Health 
Checks 
Author 
/ Year 
Study design/setting 
 
Sample 
characteristics 
where reported 
 Age Gender Ethnicity Deprivation 
(area-level) 
Other 
Public 
Health 
England 
[22] 
Published data, whole of 
England 
Whole population 
data 
48.2%  Not reported     
Attwood 
2015[34] 
Triala  set in 4 GP practices in 
the East of England 
1,380 patients 
Mean age: 52.4 
Male: 49.7% 
White: 72.9% 
27.0% For each 
increasing year:  
1.05 (1.04-1.07)* 
Female: 
1.29 (0.95-1.76) 
Compared to 
white: 
Other:  
0.85 (0.29-2.52) 
Most deprived  
quintile 
compared to 
least deprived: 
0.42 (0.20-0.88)* 
---
c 
Cochrane 
2013[33] 
Observational study using 
electronic practice records 
from 37 (of 57) GP practices 
in Stoke on Trent 
10.483 high risk 
patients  
Aged >55: 79.6% 
Aged >65: 36.4%  
Male: 81.3% 
43.7% Change in odds 
moving to next 
category higher 
IRUDJH-<55, 
-DQG 
1.64 (1.51-1.77)* 
Female:  
0.70 (0.58-0.84)* 
--- Change in odds 
moving to next 
deprivation tertile 
from least 
deprived: 
1.12 (0.96-1.30) 
Change in odds moving 
to next:  
Higher risk category 
--<35% 
DQGHVWLPDWHG
year risk:  
0.90 (0.80-1.02) 
Larger practice size 
-<7000 and 
 
1.03 (0.88-1.20) 
Coffee 
2015 d  
[12] 
Observational study using 
data from 2 community 
medical centres in 
Birmingham  
188 patients already 
using secondary 
mental health 
services 
71.8% Not reported  
Coghill 
2016 d [14] 
 
 
Quasi-experimental 
study/Electronic practice 
records of 17 GP practices in 
Bristol 
5,678 patients 
 
34.1% Compared to age 
40-69: 
Age 70-74: 2.09* 
Male: 0.82* --- Least deprived 
quintile  most 
likely to attend 
--- 
Cook 
2016[26] 
 
 
Observational study using 
electronic practice records 
from 30 (all) GP practices in 
Luton 
50.485 patients 
Aged>55: 30.5% 
Aged>65: 7.6% 
Male: 53.3% 
White British: 32.5% 
43.7% Not reported / Unadjusted differences reported in Appendix Table A3 
Dalton 
2011[32] 
Observational study using 
electronic practice records 
5,294 high risk 
patients  
44.8% Compared to age 
35-54: 
Age 35-54b:   
Female 
Compared to 
white:  
--- Practice size: 
Compared to 3000-5999 
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from 29 (of 86) GP practices 
in Ealing, London 
 
 
Aged>55: 80.8% 
Aged >65: 40.8%  
Male: 80.9% 
White British: 21.7% 
Age 55-64:  
1.74 (1.34-2.25)* 
Age 65-74:  
2.27 (1.47-3.50)* 
1.71 (1.03-2.85)* 
Aged 55-64:  
Female 
1.22 (0.89-1.67) 
Aged 65-74: 
Female   
0.96 (0.76-1.22) 
South Asian: 
1.71 (1.29-2.27)* 
Mixed race:  
2.42 (1.50-3.89)* 
Black: 
1.34 (0.91-1.98) 
Other: 
1.15 (0.76-1.74) 
Missing: 
0.51 (0.30-0.88)* 
<3000: 2.53 (1.09-5.84)* 
-1.88) 
Hypertension: 
1.31 (1.15-1.51)* 
Smoker:  
0.88 (0.75-1.02) 
Hooper 
2014[31] 
Observational study using 
data from 40 GP practices in 
Warwickshire 
37,236 patients 
 
 
44.8% Not reported  
Krska 
2015[27] 
Observational study using 
electronic practice records in 
13 (of 55) GP practices in 
Sefton, North West England 
 
2,892 high risk 
patients   
Aged >65: 69.4% 
Male: 78.3% 
White: 99.1% 
52.9% Not reported / Univariate analyses in Appendix Table A3 
Kumar 
2011[30] 
 
 
Observational study using 
data from 2 (of approx. 57) 
GP practices in Stoke on Trent 
 
1,606 patients (of 
whom 661 were high 
risk patients) 
Aged >60: 31.5% 
Male: 56.7% 
30.9% Not reported  
NHS 
Greenwich 
[16] 
Observational study using 
data from 5 community based 
venues in South East London  
1,400 patients 
Aged >65: 27.5% 
Male: 45.1% 
45.9% Not reported  
Sallis 
2016[35] 
 
 
Pragmatic quasi-randomised 
controlled trial in 4 GP 
practices in Medway 
3511 patients 
Mean Age: 53.1 
Male: 49.1% 
31.4% For each increase 
in 10 years:  
1.62 (1.50-1.75) * 
Female:  
1.50 (1.29-1.74) * 
--- Least deprived 
quintile 
compared to 
most deprived 
1.61 (1.14-2.26)* 
--- 
Results presented as adjusted odds ratios 
* p<0.05   ns: not significant 
a data from control arm of trial who attended NHS health checks; b reported with age interaction;  c the model also controlled for GP practice (n=4). 
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Table 4. Studies with a comparison group reporting the health-related impact of the NHS Health Check 
Study characteristics RESULTS 
Author 
/ Year 
 
Study design/Setting 
Study time period 
Comparison and  
Statistical Method 
Disease detection Health-
related 
behaviours 
Individual-risk factors / CVD risk 
reduction 
Prescribing 
Chang 
2016[20] 
 
Individual-level matched 
cohort study using 
CPRD data 
 
Baseline: 
April 2009 - March 2013  
Follow-up: 
Median of 2 years 
Difference in difference 
analysis comparing attendees 
with non-attendees with 
propensity score matching on 
age, gender, ethnicity, 
deprivation and region 
AF: 0.02 (-0.02 to 0.06) 
CKD: 0.17 (0.11 to 0.23)* 
CAD: 0.02 (-0.04 to 0.08) 
FH: 0.09 (0.07 to 0.11)* 
Heart failure:  0.01 (-0.01 to 0.03) 
Hypertension:  2.99 (2.77 to 3.21)* 
PVD: 0.03 (0.01 to 0.05)* 
Stroke: -0.03 (-0.05 to -0.01)* 
TIA: 0.008 (-0.01 to 0.03) 
T2DM: 1.31 (1.17 to 1.45)* 
Smoking 
prevalence: 
-0.11  
(-0.35 to 0.13) 
CVD risk:-0.21% (-0.24 to -0.19)* 
SBP: -2.51mmHg (-2.77 to -2.25)* 
DBP: -1.46mmHg  (-1.62 to -
1.29)* 
BMI: -0.27 (-0.34 to -0.20)* 
Cholesterol: -0.15mmol/L  
(-0.18 to -0.13)* 
Increase in statin 
prescribing: 
3.83 (3.52 to 4.14)* 
 
Increase in anti-
hypertensive 
prescribing: 
1.37 (1.08 to 1.66)* 
Forster 
2015[19] 
 
Individual-level matched 
cohort study using 
CPRD data 
April 2009 - March 2013 
Cohort study comparing 
attendees with non-attendees 
matched on age, gender and 
general practice 
Hypertension:  
Men:  +5%*; Women:  ns 
Hypercholesterolemia:  
Men:  +33%* ; Women  +32%* 
--- --- New statin prescribing: 
HR 1.58 (1.53 to 1.63)* 
New antihypertensive 
drug prescribing:  
HR 1.06 (1.03 to 1.10)* 
Caley 
2014[36] 
 
Observational study 
using electronic medical 
records in 79 GP 
practices in 
Warwickshire 
June 2010 ± March 2013 
(39 months) 
Multivariable regression 
analysis reporting association 
between % eligible 
completing an NHS Health 
Check at practice level and 
change in prevalence of five 
conditions 
Observed change in prevalence of 
T2DM, hypertension, CHD, CKD, 
AF was not statistically significant 
--- --- --- 
Jamet 
2014[15]   
 
 
Observational study 
using prescription data in 
145 PCTs in England 
2012 (1 year) 
Multivariable regression 
analysis reporting association  
between number of NHS 
Health Checks completed and 
statin prescribing at PCT level 
--- --- --- Prescriptions of high 
dose statins: regression 
coefficient  0.094*  
Prescriptions of low dose 
statins: Not significant  
Lambert 
2016[37] 
 
Observational study 
using local data returned 
from GP practices to 
commissioners in 3 
health districts (101 
practices) in North East 
England 
Unclear year 30 months 
Univariate regression models 
reporting association  between 
number of NHS Health 
Checks provided in the health 
district and incident cases of 
disease 
The number of health checks 
performed explained almost none 
(1% or less) of the growth in 
hypertension or diabetes registers 
and 6-60% of incident cases of 
hypertension 
--- 77±92% of variance between 
practices in numbers of incident 
high risk of cardiovascular 
disease was explained by the 
number of health checks 
performed. 
--- 
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* p<0.05; CPRD ± Clinical Practice Research Datalink; AF- atrial fibrillation; CKD ± chronic kidney disease; CAD ± coronary artery disease; FH ± familial 
hypercholesterolaemia; PVD ± peripheral vascular disease; TIA ± transient ischaemic attack; T2DM ± type 2 diabetes; DBP ± diastolic blood pressure; SBP ± systolic blood 
pressure; BMI ± body mass index; HR ± hazard ratio; CHD ± coronary heart disease 
